Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Roche acquires biotech firm Inflazome for $449m

pharmaceutical-technologySeptember 22, 2020

Tag: Roche , Inflazome , NLRP3 inhibitors

PharmaSources Customer Service